Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 6/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.46 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10002123 | 0.92 | DNM1 (0.50) | DNM1SLC22A1SLC22A2ALDH1A1TP53 | |
| SCHEMBL28465064 | 0.92 | SLC22A1 (0.50) | DNM1SLC22A1ALDH1A1CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL8694682 | 0.90 | SLC22A1 (0.47) | DNM1SLC22A1CYP3A4TSHR | |
| SCHEMBL10002130 | 0.90 | SLC22A1 (0.47) | DNM1SLC22A1ALDH1A1CYP3A4TSHR | |
| SCHEMBL20175886 | 0.88 | SLC22A1 (0.50) | DNM1SLC22A1SLC22A2 | |
| SCHEMBL9422187 | 0.88 | DNM1 (0.68) | DNM1SLC22A1SLC22A2ALDH1A1TP53 | |
| SCHEMBL8172964 | 0.88 | DNM1 (0.68) | DNM1SLC22A1SLC22A2ALDH1A1TP53 | |
| SCHEMBL474332 | 0.88 | DNM1 (0.68) | DNM1SLC22A1SLC22A2ALDH1A1TP53 | |
| SCHEMBL28122416 | 0.88 | DNM1 (0.68) | DNM1SLC22A1SLC22A2ALDH1A1TP53 | |
| Bromide SCHEMBL23573666 | 0.87 | DNM1 (0.56) | DNM1SLC22A1ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120053092-A1 | Shale Hydration Inhibition Agents for Utilization in Water-based Drilling Fluids | ST. FRANCIS XAVIER UNIVERSITY (CA) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053092-A1 | Shale Hydration Inhibition Agents for Utilization in Water-based Drilling Fluids | AQP1, AQP3, SLC26A4 | DNM1 283/4885SLC22A1 146/4885SLC22A2 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.